Related Experiment Video
Updated: May 13, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Lipidomics in drug and biomarker development
1National University of Singapore, Yong Loo Lin School of Medicine, Department of Biochemistry and Department of Biological Sciences, 8 Medical Drive, Block MD7, 117597 Singapore. bchmrw@nus.edu.sg.
Abstract:
Lipidomics is an emerging field in biomedical research. It aims at systems scale detection, characterisation and quantification of lipids. Lipidomics is developing as an independent discipline at the interface of lipid biology, technology and medicine. Technological advancements, most notably in liquid chromatography and mass spectrometry, allow sensitive and highly selective analysis of lipids with diverse chemical composition and in complex mixtures. Comparative analysis of such lipid profiles, which stem from two physiologically linked conditions is particularly powerful for applications in drug and biomarker development. First, it leads to the identification of pathways related to lipid metabolism. Second, multiparameter lipid biomarkers will provide better diagnostics in preclinical trials using model organisms and in clinical presentations in humans.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Biotransformation: Overview

